FDA to Issue Strongest Warning on Covid-19 Vaccines
The US Food and Drug Administration is considering adding a “black box” warning to Covid-19 vaccines, a move that has sparked controversy and raised concerns among public health experts.
According to two sources familiar with the agency’s plans, the proposed warning is being driven by officials within President Donald Trump’s administration, potentially undermining confidence in a vaccine considered a major success of his first term. A boxed warning, the most serious type issued by the FDA, highlights risks of death, serious harm, or reactions that must be carefully weighed against benefits.
Currently, boxed warnings are used for medications like opioids – warning of abuse and overdose – and Accutane, which carries risks of birth defects. The FDA’s consideration comes after a memo from Dr. Vinay Prasad, the agency’s chief medical and scientific officer, alleging that at least 10 children have died following Covid-19 vaccination, though he has not publicly released supporting data.
The Department of Health and Human Services spokesperson, Andrew Nixon, stated, “Unless the FDA announces it, any claim about what it will do is pure speculation.”
Both Moderna and Pfizer have issued statements reaffirming the safety of their vaccines. Moderna noted that over a billion doses have been administered globally with “no new or undisclosed safety concerns in children or pregnant women.” Pfizer declined further comment after its initial statement.
Despite the concerns raised, data suggests the vaccines remain highly effective. One study estimated that Covid-19 vaccinations averted nearly 20 million deaths worldwide. A recent CDC report also indicated that vaccinated children experienced a “substantially lower risk” of emergency department and urgent care visits during the 2024-25 respiratory virus season – approximately 76% effectiveness for those aged 9 months to 4 years, and 56% for children aged 5 to 17.
The move by the FDA is seen by some as a political maneuver. President Trump’s initial push for rapid vaccine development, dubbed Operation Warp Speed, was hailed as a triumph. However, his appointment of vaccine skeptic Robert F. Kennedy Jr. as Health and Human Services Secretary has raised eyebrows.
Critics argue that the administration is attempting to manufacture evidence against the vaccines. Dr. Aaron Kesselheim of Harvard University expressed concern over the lack of transparency and a proper review process. “I guess my concern is that in this case, there’s not a process,” he said. “There isn’t that same opportunity for discussion and good-faith review of the data on which this decision is being made.”
Dr. Fiona Havers, a former CDC medical epidemiologist, emphasized the importance of balancing potential risks with the proven benefits of vaccination. “But to only talk about potential harms for vaccines, without talking about the thousands of hospitalizations and the many pediatric deaths that these vaccines prevented, is irresponsible,” she stated.
The FDA has also been looking into potential links between the vaccines and deaths across multiple age groups, focusing on rare side effects like myocarditis, or heart inflammation, particularly in young men. While myocarditis has been observed, the CDC reports that most cases resolve without long-term complications.
The situation remains fluid, and the FDA has not yet finalized any decisions. The agency maintains that all safety concerns are being thoroughly reviewed based on rigorous, independent data evaluation.
Image Source: MYJOYONLINE
